HPH-15 10 mg | ≥98% Cayman Chemical An antifibrotic compound and AMPK activator More Information Supplier Page × HPH-15
HPH-15 1 mg | ≥98% Cayman Chemical An antifibrotic compound and AMPK activator More Information Supplier Page × HPH-15
6-PPD-Q-4-OH 500 µg | ≥95% Cayman Chemical A metabolite of 6-PPD-Q More Information Supplier Page × 6-PPD-Q-4-OH
6-PPD-Q-4-OH 5 mg | ≥95% Cayman Chemical A metabolite of 6-PPD-Q More Information Supplier Page × 6-PPD-Q-4-OH
6-PPD-Q-4-OH 1 mg | ≥95% Cayman Chemical A metabolite of 6-PPD-Q More Information Supplier Page × 6-PPD-Q-4-OH
Lyso-Monosialoganglioside GM3 (synthetic) 500 µg | ≥98% Cayman Chemical A ganglioside More Information Supplier Page × Lyso-Monosialoganglioside GM3 (synthetic)
DMG-PEG(2000) (solution) 500 µL | ≥90% Cayman Chemical A lipid excipient More Information Supplier Page × DMG-PEG(2000) (solution)
DMG-PEG(2000) (solution) 2.5 mL | ≥90% Cayman Chemical A lipid excipient More Information Supplier Page × DMG-PEG(2000) (solution)
DMG-PEG(2000) (solution) 1 mL | ≥90% Cayman Chemical A lipid excipient More Information Supplier Page × DMG-PEG(2000) (solution)
[Lys5,Tyr6,mLeu9,Nle10]-Neurokinin A (4-10) (trifluoroacetat 5 mg | ≥95% Cayman Chemical A neurokinin A derivative and fragment of EB1001 More Information Supplier Page × [Lys5,Tyr6,mLeu9,Nle10]-Neurokinin A (4-10) (trifluoroacetat
